OneTouch(R) Ping(TM) Glucose Management System Approved By Health Canada
Main Category: DiabetesAlso Included In: Medical Devices / Diagnostics; Regulatory Affairs / Drug Approvals
Article Date: 16 Jul 2009 - 1:00 PDT
| Patient / Public: | ![]() |
3.5 (2 votes) |
| Healthcare Prof: | ![]() |
4 (1 votes) |
Animas Corporation announced the approval of its OneTouch((R)) Ping(TM) Glucose Management System by Health Canada. OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.
"OneTouch Ping provides patients with unique capabilities designed to make life with diabetes easier and more discreet. A combination of the advanced insulin pump technology from Animas and trusted OneTouch blood glucose monitor technology, the OneTouch Ping frees people living with diabetes from multiple daily injections, while offering discretion and convenience through remote insulin dosing," said Henry Anhalt, D.O., Director of Medical Affairs, Animas Corporation. "Animas is pleased to bring this advancement to people with diabetes in Canada."
OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson: Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch((R)) Ultra((R)) Test Strips.
OneTouch Ping also offers the following:
-- Lifestyle-focused pump performance - the pump can be clipped to a belt, tucked in a pocket, or secured under clothing, is waterproof up to 3.6 meters (12 feet) for 24 hours, and has a color screen for outstanding pump readability
-- Individualized control - delivers lowest basal increments (0.025 U/hr) and lowest bolus increments (0.05 U) available to more precisely match patient insulin needs
-- Proven blood glucose monitoring technology - the meter-remote utilizes the OneTouch((R)) Ultra((R)) test strip, the #1-selling test strip in Canada and #1 test strip preferred among insulin users in Canada.( )OneTouch((R)) Ultra((R)) test strips have more than 6 years of proven accuracy and use patented DoubleSure(TM) technology to automatically check and confirm results for accuracy
ezManager((R)) MAX Diabetes Management Software
The OneTouch Ping system will also work with the ezManager((R)) MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager((R)) MAX software is MAC and PC compatible.
About Animas Corporation
As part of the Johnson & Johnson Family of Companies, Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas 2020 insulin pump, inset 30 infusion set, ezManager MAX software and the new OneTouch Ping glucose management system. Animas, from the Latin word meaning true inner self or soul, has been committed since 1996 to individual patient needs through the development of life-performance technology and unparalleled customer service live 24 hours a day, 7 days a week, 365 days a year.
About LifeScan, Inc.
LifeScan, Inc., a Johnson & Johnson company and the leading maker of blood glucose monitoring products, is dedicated to creating a world without limits for people with diabetes. The company develops, manufactures, and markets a wide range of glucose monitoring systems and software for use by people with diabetes and health care providers.
Source: Animas Corporation
Visit our diabetes section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/157678.php>
APA
http://www.medicalnewstoday.com/releases/157678.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





